Brief: Baijin Life Science Says Unit Enters Strategic Cooperation Framework Agreement With Foryoung Biotechnology
06/05/2026 12:03
May 6 (Reuters) - Baijin Life Science Holdings Ltd 1466.HK: SUBSIDIARY ENTERS STRATEGIC COOPERATION FRAMEWORK AGREEMENT WITH FORYOUNG BIOTECHNOLOGY BEIJING BAIJIN TO HANDLE RD, PRODUCTION, QUALITY CONTROL, AND SUPPLY CHAIN UNDER AGREEMENT FORYOUNG BIOTECHNOLOGY TO PROVIDE EXPERTISE, PATENTS, AND MARKET CAPABILITIES IN COOPERATION Further company coverage: 1466.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Baijin Life Science Holdings
See all newsBrief: Baijin Life Science Says Unit Enters Strategic Cooperation Framework Agreement With Foryoung Biotechnology
Brief: Baijin Life Science Says Unit To Invest In Guhuan Medical For Sales Channel
Brief: Baijin Life Science Expects Net Profit Of HK$2.5 Million For HY
Brief: Baijin Life Science Says Beijing Baijin To Invest In Youhuan Bio For Circrna Platform
Brief: Baijin Life Science Enters Subscription Agreements For Aggregate Of 40 Million Shares At HK$0.48 Per Share